Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1b Study of Pidnarulex and Trastuzumab Deruxtecan in Patients With HER2 Expressing Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07137416
Title field or adapter rule
{'original_value': 'Phase 1b Study of Pidnarulex and Trastuzumab Deruxtecan in Patients With HER2 Expressing Solid Tumors', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:30.608950+00:00
Published At
2026-10-16T00:00:00+00:00
Record Updated At
2026-10-16
Source Retrieved At
2026-10-31T22:18:22.973355+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Anatomic Stage III Breast Cancer AJCC v8", "Anatomic Stage IV Breast Cancer AJCC v8", "Invasive Breast Carcinoma", "Locally Advanced Breast Carcinoma", "Metastatic Breast Carcinoma", "Metastatic HER2-Low Breast Carcinoma", "Metastatic HER2-Positive Breast Carcinoma", "Metastatic Hormone Receptor-Positive Breast Carcinoma", "Metastatic Malignant Solid Neoplasm", "Metastatic Triple-Negative Breast Carcinoma", "Unresectable Breast Carcinoma", "Unresectable HER2-Low Breast Carcinoma", "Unresectable HER2-Positive Breast Carcinoma", "Unresectable Hormone Receptor-Positive Breast Carcinoma", "Unresectable Malignant Solid Neoplasm", "Unresectable Triple-Negative Breast Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-16", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07137416"
protocolSection.identificationModule.officialTitle
"Phase 1b Study of Pidnarulex and Trastuzumab Deruxtecan in Patients With HER2 Expressing Solid Tumors"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Anatomic Stage III Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Anatomic Stage IV Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Invasive Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic HER2-Low Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic HER2-Positive Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Hormone Receptor-Positive Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Metastatic Triple-Negative Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable HER2-Low Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable HER2-Positive Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Hormone Receptor-Positive Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Unresectable Triple-Negative Breast Carcinoma (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Treatment (Pidnarulex, T-DXd)'], 'description': 'Undergo biopsy', 'name': 'Biopsy Procedure', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (Pidnarulex, T-DXd)'], 'description': 'Undergo collection of blood samples', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (Pidnarulex, T-DXd)'], 'description': 'Undergo ECHO', 'name': 'Echocardiography Test', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (Pidnarulex, T-DXd)'], 'description': 'Undergo MUGA', 'name': 'Multigated Acquisition Scan', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (Pidnarulex, T-DXd)'], 'description': 'Given IV', 'name': 'Pidnarulex', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (Pidnarulex, T-DXd)'], 'description': 'Undergo radiologic imaging', 'name': 'Radiologic Imaging Procedure', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (Pidnarulex, T-DXd)'], 'description': 'Given IV', 'name': 'Trastuzumab Deruxtecan', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Pidnarulex (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.